Replies to post #411739 on NorthWest Biotherapeutics Inc (NWBO)

[skitahoe]

Sir P,

We shouldn't be looking at DCVax-L or Direct replacing all the other therapeutics, it really is working with them. If you have a product that's extending the lives of a certain type of cancer patient by 30%, wouldn't you rather extend it by 80% or perhaps achieve a cure. That's the difference the vaccine could be making. If you're the BP that makes the chemo that works with DCVax's you'll be happy to have them on the market, your patients will live longer and they'll use more of your product.

Certainly some of the BP's would like to own the DCVax's for themselves, and that could come to pass, or they might partner with NWBO, but remember that by itself the vaccines are not enough to cure the cancers. Dr. Liau has basically said that multiple therapeutics are needed to cure GBM or other cancers, our vaccine is one of what's needed, she's working to find the others.

Gary